Mylan gets US FDA nod for generic Cytomel to treat thyroid deficiency
Saturday, July 18, 2009 12:00 IST Pittsburgh
Mylan Inc announced that its subsidiary Mylan Pharmaceuticals Inc has received approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Liothyronine Sodium tablets USP
